We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
Cap. Flow
-$2.97B
Cap. Flow %
-3.9%
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$77.3M
2
BX icon
Blackstone
BX
+$53.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$40.8M
4
PLTR icon
Palantir
PLTR
+$34.3M
5
SNOW icon
Snowflake
SNOW
+$24.8M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$163M
3
LIN icon
Linde
LIN
+$133M
4
AMZN icon
Amazon
AMZN
+$94.7M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$82.6M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Financials 14.16%
3 Healthcare 12.95%
4 Consumer Discretionary 12.06%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNC icon
1501
Tennant Co
TNC
$1.31B
$4.32M 0.01%
54,051
-1,076
-2% -$88K
ALG icon
1502
Alamo Group
ALG
$2.02B
$4.3M 0.01%
28,142
-1,474
-5% -$229K
FARO
1503
DELISTED
Faro Technologies
FARO
$4.29M 0.01%
55,197
+2,526
+5% +$199K
USPH icon
1504
US Physical Therapy
USPH
$1.16B
$4.28M 0.01%
36,965
-1,521
-4% -$175K
LPRO
1505
DELISTED
Open Lending Corp
LPRO
$4.27M 0.01%
+99,108
New +$3.81M
RETA
1506
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$4.27M 0.01%
30,169
+4,779
+19% +$540K
RWT
1507
Redwood Trust
RWT
$573M
$4.26M 0.01%
353,371
-14,404
-4% -$161K
MARA icon
1508
Marathon Digital Holdings
MARA
$4.06B
$4.24M 0.01%
+135,133
New +$4.29M
CNNE icon
1509
Cannae Holdings
CNNE
$652M
$4.24M 0.01%
124,966
-8,080
-6% -$301K
SPY icon
1510
State Street SPDR S&P 500 ETF Trust
SPY
$818B
$4.23M 0.01%
9,885
CYH icon
1511
Community Health Systems
CYH
$416M
$4.23M 0.01%
273,751
-5,014
-2% -$68.1K
APLS
1512
DELISTED
Apellis Pharmaceuticals
APLS
$4.23M 0.01%
66,869
+2,037
+3% +$105K
RDNT icon
1513
RadNet
RDNT
$5.36B
$4.22M 0.01%
125,220
-2,870
-2% -$75.6K
AZZ icon
1514
AZZ Inc
AZZ
$4.53B
$4.22M 0.01%
81,465
-4,699
-5% -$247K
CALM icon
1515
Cal-Maine
CALM
$3.98B
$4.22M 0.01%
116,468
+1,179
+1% +$44.1K
BBBY
1516
Bed Bath & Beyond
BBBY
$429M
$4.21M 0.01%
50,223
-5,654
-10% -$411K
LSXMA
1517
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$4.21M 0.01%
122,890
-6,487
-5% -$213K
ICHR icon
1518
Ichor Holdings
ICHR
$2.45B
$4.2M 0.01%
78,090
+1,793
+2% +$98.7K
CRNC icon
1519
Cerence
CRNC
$408M
$4.16M 0.01%
39,019
-19,506
-33% -$1.92M
CNS icon
1520
Cohen & Steers
CNS
$4.34B
$4.15M 0.01%
50,594
-1,562
-3% -$113K
STBA icon
1521
S&T Bancorp
STBA
$1.82B
$4.13M 0.01%
132,097
-6,760
-5% -$224K
VNDA icon
1522
Vanda Pharmaceuticals
VNDA
$308M
$4.12M 0.01%
191,724
-9,147
-5% -$164K
CXW icon
1523
CoreCivic
CXW
$3.19B
$4.12M 0.01%
393,784
-24,248
-6% -$218K
HIBB
1524
DELISTED
Hibbett, Inc. Common Stock
HIBB
$4.12M 0.01%
45,995
-8,288
-15% -$648K
MLAB icon
1525
Mesa Laboratories
MLAB
$565M
$4.1M 0.01%
15,119
+1,464
+11% +$371K

Similar funds

RhumbLine Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.

  • RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
  • RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
  • RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
  • RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
  • RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
  • RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.